🩸risk

Bone Turnover Markers — What Blood Tests Can Tell You

Formation markers (P1NP, BAP) and resorption markers (CTX, NTX) explained with a simple "demolition crew vs. construction crew" analogy.

A DXA scan tells you how dense your bones are at a single point in time, like a photograph. Bone turnover markers show your bones in motion. They are blood (and sometimes urine) tests that show how actively your bones are being broken down and rebuilt right now, so your doctor can see your bone metabolism as it is today.

If your doctor has ordered bone marker tests, or if you are curious about what these tests can tell you, this article explains the main markers in plain language.

1

What you'll learn on this page

  • What bone turnover markers are and why they matter
  • Formation markers: P1NP and BAP (the "building team")
  • Resorption markers: CTX and NTX (the "demolition team")
  • How to interpret high or low values
  • How doctors use these markers to guide treatment
  • Important limitations to understand
2

What are bone turnover markers?

As we described in Your Bones Are Alive, your bones are constantly being broken down (resorption) and rebuilt (formation) in a process called remodeling. Each time this happens, the cells involved release specific molecules into the bloodstream. By measuring these molecules, doctors can tell how fast bone remodeling is going.

If bone remodeling is a construction site, bone turnover markers are like the dust and noise that tell you how much work is going on, even if you cannot see inside the building.

There are two main categories:

  • Formation markers: released when new bone is being built. These show the activity of osteoblasts (the building team).
  • Resorption markers: released when bone is being broken down. These show the activity of osteoclasts (the demolition team).

A DXA scan shows you where things stand. Bone turnover markers show you where things are heading.

3

Formation markers: the building team

When osteoblasts build new bone, they produce specific proteins and enzymes that spill into the bloodstream. Measuring these tells your doctor how actively your body is making new bone.

Osteoblasts building bone and releasing formation markers (P1NP, BAP)

P1NP (Procollagen type 1 N-terminal propeptide)

P1NP is currently the preferred formation marker recommended by the International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry (IFCC).

  • What it measures: When osteoblasts produce type 1 collagen (the main structural protein of bone), they release a fragment called P1NP into the blood
  • What it reflects: The rate at which new bone collagen is being formed
  • Sample type: Blood test (serum)
  • Main advantage: P1NP is fairly stable throughout the day, so the time of the blood draw matters less

BAP (Bone-specific Alkaline Phosphatase)

  • What it measures: An enzyme produced by osteoblasts during the mineralization phase of bone formation (when calcium and other minerals are laid down on the collagen framework)
  • What it reflects: The rate of bone mineralization
  • Sample type: Blood test (serum)
  • Note: Total alkaline phosphatase (ALP) is a common blood test, but part of it comes from the liver and other organs. BAP is the bone-specific version and is more accurate for assessing bone formation

What high or low formation markers mean

Level Possible meaning
High Active bone formation. Could indicate healing fractures, a response to bone-building treatment, Paget's disease, or other metabolic bone conditions
Low Reduced bone formation. Could indicate suppressed remodeling from bone-preserving treatment, or naturally low bone turnover
Normal Bone formation is within the expected range
4

Resorption markers: the demolition team

When osteoclasts break down bone, they release fragments of bone tissue into the bloodstream and urine. Measuring these fragments tells your doctor how actively bone is being broken down.

Osteoclasts breaking down bone and releasing resorption markers (CTX, NTX)

CTX (C-terminal telopeptide of type 1 collagen)

CTX is the preferred resorption marker recommended by the IOF/IFCC.

  • What it measures: When osteoclasts break down bone collagen, they release small fragments called cross-linked telopeptides. CTX is a specific fragment from the C-terminal end
  • What it reflects: The rate of bone collagen breakdown
  • Sample type: Blood test (serum), called s-CTX or beta-CTX
  • Important: CTX levels vary a lot through the day and are affected by eating. A fasting morning blood draw is essential for accurate results

NTX (N-terminal telopeptide of type 1 collagen)

  • What it measures: Similar to CTX, but from the N-terminal end of the collagen molecule
  • Sample type: Can be measured in blood (serum) or urine
  • Note: Urine NTX was widely used in the past, but serum CTX has largely replaced it in clinical practice because it is more convenient and more reliable

What high or low resorption markers mean

Level Possible meaning
High Rapid bone breakdown. Common in early postmenopause, hyperparathyroidism, hyperthyroidism, or untreated osteoporosis. Means bone is being lost faster than it is being replaced
Low Reduced bone breakdown. Typical during treatment that slows bone breakdown, and often the intended treatment effect
Normal Bone breakdown is within the expected range
5

How your results might look

Reading bone marker results on a blood test report

A typical bone marker blood test report shows your values next to a reference range. Here is a simplified example:

Marker Your value Reference range Category
P1NP 45 ng/mL 15-75 ng/mL Formation
CTX 0.55 ng/mL 0.10-0.50 ng/mL Resorption

In this example, P1NP is within the normal range (bone building is going normally), but CTX is slightly high (bone breakdown is higher than average). This pattern could suggest that bone is being broken down a bit faster than it is being replaced. That is a common finding in postmenopausal women who are not yet on treatment.

Bone marker results are best interpreted by your doctor alongside your overall health, DXA results, and clinical history. A single value on its own can be misleading.

6

How doctors use bone markers in practice

1. Assessing treatment response

This is the most common clinical use. After you start osteoporosis treatment, your doctor may order bone markers at 3-6 months to see if it is working:

  • Treatment that slows bone breakdown: CTX should fall clearly within 3-6 months. A drop of about 25-30% or more from baseline generally means the treatment is working.
  • Treatment that builds new bone: P1NP should rise, showing that new bone formation is being stimulated.

This helps because DXA scans can take 1-2 years to show measurable changes. Bone markers give a much earlier signal.

2. Monitoring medication adherence

If someone is on treatment to slow bone breakdown but their CTX levels have not changed after 3-6 months, the treatment may not be absorbed properly or may not be taken as directed. Your doctor can help work out what's going on.

3. Baseline assessment

Some doctors order bone markers at the same time as a DXA scan to get a fuller picture of bone health. A person with borderline osteopenia but very high resorption markers may be at greater risk of rapid bone loss than their DXA score alone would suggest.

4. Detecting high-turnover states

High markers (both formation and resorption) can point to conditions like Paget's disease, hyperparathyroidism, or metastatic bone disease. They can also flag secondary causes of osteoporosis that may need separate treatment.

7

Important limitations

Bone turnover markers are useful, but they have some limits:

Biological variability

Bone markers naturally rise and fall from day to day and even during the day. CTX in particular follows a strong circadian rhythm: levels are highest in the early morning and lowest in the afternoon. Eating also lowers CTX levels. This is why a fasting morning blood draw is standard.

Conditions that affect results

Several factors can change bone marker levels apart from osteoporosis:

  • Recent fractures: markers will be high while the body heals
  • Kidney disease: slows how the body clears the markers and skews results
  • Liver disease: can affect some markers (especially total ALP)
  • Vitamin D deficiency: can raise resorption markers
  • Pregnancy and growth: naturally raise all bone markers

They are not diagnostic

Bone markers alone cannot diagnose osteoporosis. They add to DXA scans; they do not replace them. A normal DXA with high markers, or low bone density with normal markers, each means something different.

Limited standardization

Different laboratories may use different assays and reference ranges. To compare results over time as accurately as possible, try to have your bone markers tested at the same laboratory.

Bone markers are a useful addition to your doctor's tools, but they work best together with DXA scans and clinical assessment.

8

Frequently Asked Questions

Q. Do I need to fast before bone marker blood tests?

For CTX (resorption marker): Yes. A fasting morning blood draw is strongly recommended because eating lowers CTX levels. Usually you fast overnight and have the blood drawn in the morning before eating.

For P1NP (formation marker): Fasting matters less because P1NP is fairly stable throughout the day. However, many doctors order both markers together, so a fasting morning draw covers both.

Q. How often are bone markers tested?

It depends on the clinical situation. Common patterns include:

  • Baseline: When osteoporosis is first diagnosed or when treatment begins
  • 3-6 months after starting medication: To check if treatment is working
  • Annually: For ongoing monitoring in some cases
  • When changing medications: To set a new baseline

Q. My bone markers are high. Does that mean I have osteoporosis?

Not necessarily. High bone markers mean increased bone turnover, which can happen in many situations, including healing fractures, vitamin D deficiency, hyperparathyroidism, and other conditions. High turnover is a risk factor for bone loss, but diagnosing osteoporosis requires a DXA scan. High markers suggest your bones are very active, but only a DXA scan tells you whether the net result is adequate bone density.

Q. Can I request bone marker tests on my own?

In some countries and healthcare systems, you can request laboratory tests directly. However, the results need clinical context. It is best to have your doctor order and review them so they can be read alongside your medical history, DXA results, and other findings.

Q. Are there other bone markers I should know about?

The ones most commonly used in clinical practice are P1NP and CTX, as recommended by the IOF/IFCC. Other markers you might come across include:

  • Osteocalcin: a formation marker produced by osteoblasts
  • TRACP-5b: a resorption marker released by osteoclasts (less affected by kidney function than CTX)
  • Deoxypyridinoline (DPD): a urine resorption marker, now largely replaced by serum CTX

Your doctor will choose the most suitable markers for your situation and what your local laboratory offers.

9

References

  • Vasikaran S et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporosis International, 2011; 22: 391-420. (IOF/IFCC Joint Position Statement)
  • Eastell R et al. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes & Endocrinology, 2017; 5(11): 908-923.
  • International Osteoporosis Foundation (IOF). Bone Turnover Markers. https://www.osteoporosis.foundation/health-professionals/diagnosis/bone-turnover-markers
  • Szulc P, Delmas PD. Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporosis International, 2008; 19: 1683-1704.
  • Naylor K, Eastell R. Bone turnover markers: use in osteoporosis. Nature Reviews Rheumatology, 2012; 8: 379-389.
)}

Medical Supervision

Hiroyuki Katoh(Orthopedic Surgeon, board-certified by the Japanese Orthopaedic Association)

Last updated:March 21, 2026